Proteogenomic Characterization of Human Early-Onset Gastric Cancer
Dong-Gi Mun,Jinhyuk Bhin,Sangok Kim,Hyunwoo Kim,Jae Hun Jung,Yeonjoo Jung,Ye Eun Jang,Jong Moon Park,Hokeun Kim,Yeonhwa Jung,Hangyeore Lee,Jingi Bae,Seunghoon Back,Su-Jin Kim,Jieun Kim,Heejin Park,Honglan Li,Kyu-Baek Hwang,Young Soo Park,Jeong Hwan Yook,Byung Sik Kim,Sun Young Kwon,Seung Wan Ryu,Do Youn Park,Tae Yong Jeon,Dae Hwan Kim,Jae-Hyuck Lee,Sang-Uk Han,Kyu Sang Song,Dongmin Park,Jun Won Park,Henry Rodriguez,Jaesang Kim,Hookeun Lee,Kwang Pyo Kim,Eun Gyeong Yang,Hark Kyun Kim,Eunok Paek,Sanghyuk Lee,Sang-Won Lee,Daehee Hwang
DOI: https://doi.org/10.1016/j.ccell.2018.12.003
IF: 50.3
2019-01-01
Cancer Cell
Abstract:We report proteogenomic analysis of diffuse gastric cancers (GCs) in young populations. Phosphoproteome data elucidated signaling pathways associated with somatic mutations based on mutation-phosphorylation correlations. Moreover, correlations between mRNA and protein abundances provided potential oncogenes and tumor suppressors associated with patient survival. Furthermore, integrated clustering of mRNA, protein, phosphorylation, and N-glycosylation data identified four subtypes of diffuse GCs. Distinguishing these subtypes was possible by proteomic data. Four subtypes were associated with proliferation, immune response, metabolism, and invasion, respectively; and associations of the subtypes with immune- and invasion-related pathways were identified mainly by phosphorylation and N-glycosylation data. Therefore, our proteogenomic analysis provides additional information beyond genomic analyses, which can improve understanding of cancer biology and patient stratification in diffuse GCs.
oncology,cell biology